GLP-1 Side Effects Timeline: Week by Week, Dose by Dose

Week 1 (first dose, lowest strength)

Most patients describe week 1 as mildly off — fullness comes faster than expected, food sounds less appealing, and there's often a low-grade tiredness. True nausea is uncommon at the starting dose (0.25mg semaglutide or 2.5mg tirzepatide). The biggest mistake people make in week 1 is eating their usual portions out of habit — your stomach can't handle them and the resulting bloating feels like a side effect of the drug rather than overeating.

• Expected: reduced appetite, mild fatigue, occasional nausea, slight constipation.
• Normal: feeling full after half your usual portion.
• Action: cut portions by 30–40% proactively. Start fiber and magnesium daily.

Weeks 2–4 (settling in at the starter dose)

Most starter-dose side effects fade significantly by week 3. Your appetite suppression stabilizes, you adapt to smaller portions, and energy normalizes. This is the easy phase. Use it to build the habits that will carry you through the harder escalations: protein at every meal, daily walks, sleep on a schedule, and a tracking app.

Each dose escalation: the 5-day rule

Every time your dose increases (usually every 4 weeks early on), the side-effect arc resets. Day 1–2 after the larger injection is usually fine. Day 3–4 is when nausea, fatigue, and reflux peak. Day 5–7 you start feeling like yourself again. Knowing this lets you schedule injections strategically — many patients inject Friday or Saturday so the worst days fall on the weekend.

• Day 0 (injection day): generally fine, possible mild appetite change in the evening.
• Day 1–2: appetite drops significantly, energy may dip.
• Day 3–4: peak nausea, possible reflux, lowest energy. Hardest 48 hours.
• Day 5–7: rapid improvement, back to new baseline.

Weeks 5–12 (the escalation gauntlet)

This is when most patients quit, and it's also when the medication starts producing meaningful weight loss. The pattern is a sawtooth: each new dose is rough for a few days, then you adapt, then the next escalation hits. Constipation reaches its peak severity here for many patients, which is why proactive fiber and magnesium from day 1 matters so much. Hair shedding can also start around week 8–10 — this is from rapid weight loss, not the drug itself, and resolves once weight stabilizes.

Months 3–6 (the productive phase)

Most patients reach their effective maintenance dose somewhere in this window. Side effects become predictable and manageable. Weight loss is steady (typically 1–2 lbs per week). The main risks shift from acute GI symptoms to slow-burn issues: protein under-eating, muscle loss, and the dreaded 'Ozempic face' — facial volume loss that's actually just rapid fat loss showing up where you don't want it.

• Build a protein floor: 1.2–1.6g per pound of goal body weight.
• Start resistance training if you haven't — it's the single best muscle-preservation lever.
• Get bloodwork at 3 months: CBC, CMP, lipid panel, A1C.

Beyond 6 months (maintenance and long-term)

Once you're stable on your effective dose, side effects largely become a non-issue. Some patients continue to have mild constipation or reflux indefinitely. Annual labs are standard. Bone density screening is reasonable for patients with significant total weight loss (15%+ of body weight), particularly post-menopausal women.

Red flag symptoms — call your prescriber today

Most side effects are uncomfortable but safe. These are not.

• Severe, persistent upper-abdominal pain, especially radiating to the back — possible pancreatitis. Stop the medication and seek immediate care.
• Vomiting that prevents fluid intake for more than 24 hours — risk of dehydration and acute kidney injury.
• Vision changes — rare but reported, requires immediate evaluation.
• Severe right-upper-quadrant pain with nausea — possible gallbladder issue (gallstones are more common during rapid weight loss).
• Mood changes, especially new depression or suicidal ideation — rare but reported, talk to your prescriber.

Keep exploring

Pair this guide with cost, coverage, and program reviews.